PKMYT1 and neoplasm: As a direct downstream target of miR-485-5p, PKMYT1 was initially identified as a negative regulator of the normal cell cycle transition by inhibiting CDK1-cylin B complex via phosphorylating Tyr14/Tyr15, which is more critical for tumor cell proliferation [45].